Analysed Contineum Therapeutics Inc (CTNM:NASDAQ) News Sources
Analysts Are Bullish on These Healthcare Stocks: Inhibikase Therapeutics (IKT), MoonLake Immunotherapeutics (MLTX)
The Globe and Mail
Analysts Offer Insights on Healthcare Companies: KalVista Pharmaceuticals (KALV), Bausch Health Companies (BHC) and Insulet (PODD)
The Globe and Mail
What is the current price of Contineum Therapeutics Inc (CTNM:NASDAQ)?
The current price of Contineum Therapeutics Inc (CTNM:NASDAQ) is $15.59.
Contineum Therapeutics Inc (CTNM:NASDAQ) absolute price change since previous trading day?
The absolute price change of Contineum Therapeutics Inc (CTNM:NASDAQ) since the previous trading day is $-0.19.
Contineum Therapeutics Inc (CTNM:NASDAQ) percentage price change since previous trading day?
The percentage price change of Contineum Therapeutics Inc (CTNM:NASDAQ) since the previous trading day is -1.20%.
What is This Week's average sentiment score for Contineum Therapeutics Inc (CTNM:NASDAQ)?
This Week's average sentiment score for Contineum Therapeutics Inc (CTNM:NASDAQ) is 71 out of 100.
What is This Week's average sentiment for Contineum Therapeutics Inc (CTNM:NASDAQ)?
This Week's sentiment for Contineum Therapeutics Inc (CTNM:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.